|
99 Companies |
|
114 Products |
|
114 Products |
|
61 Mechanisms of Action |
|
11 Trials |
|
1875 News |
|
| «12345678910111213...3637» |
- | Trial completion date: HyTe-2: Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement (clinicaltrials.gov) - Jul 20, 2018
P=N/A, N=155, Suspended, Sponsor: Coxa, Hospital for Joint Replacement
Trial completion date: Jun 2018 --> Jun 2019
- | Trial completion date, Trial termination, Trial primary completion date, Surgery: Multi-centre Study to Assess the Long-term Performance of the Deltamotion Cup System in Primary Hip Replacement Surgery (clinicaltrials.gov) - Jul 19, 2018
P4, N=250, Terminated, Sponsor: DePuy International
Trial completion date: Jun 2018 --> Jun 2019 Trial completion date: Mar 2024 --> Feb 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Feb 2018
- | NN1213 / Novo Nordisk
Trial completion date: Regenexx (clinicaltrials.gov) - Jul 18, 2018
P=N/A, N=50, Active, not recruiting, Sponsor: Regenexx, LLC
Trial completion date: Mar 2024 --> Feb 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Feb 2018 Trial completion date: Jun 2018 --> Dec 2018
- | NN1213 / Novo Nordisk
Trial completion: A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) With an Interference Screw for Thumb Carpometacarpal Arthritis - Pilot Study (clinicaltrials.gov) - Jul 17, 2018
P=N/A, N=20, Completed, Sponsor: Andrew Trenholm
Trial completion date: Jun 2018 --> Dec 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial termination: Visionaire: A Prospective Study (clinicaltrials.gov) - Jul 5, 2018
P=N/A, N=149, Terminated, Sponsor: The Hawkins Foundation
Active, not recruiting --> Completed Recruiting --> Terminated; An interim analysis found the study would not be able to reach significance without a large increase in subjects which was not feasible.
- ||| Trial completion, Trial completion date: Vanguard Complete Knee Versus Vanguard High Flex Rotating Platform (RP) Knee Study (clinicaltrials.gov) - Jun 27, 2018
P=N/A, N=300, Completed, Sponsor: Zimmer Biomet
Recruiting --> Terminated; An interim analysis found the study would not be able to reach significance without a large increase in subjects which was not feasible. Active, not recruiting --> Completed | Trial completion date: Oct 2021 --> Oct 2017
- ||| NN1213 / Novo Nordisk
Trial completion: A Prospective Munti-center Study on VANGUARD (clinicaltrials.gov) - Jun 26, 2018
P=N/A, N=100, Completed, Sponsor: Zimmer Biomet
Active, not recruiting --> Completed | Trial completion date: Oct 2021 --> Oct 2017 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion date: G7 Acetabular System vs. Exceed ABT Acetabular System in THA (clinicaltrials.gov) - Jun 26, 2018
P=N/A, N=160, Active, not recruiting, Sponsor: Zimmer Biomet
Active, not recruiting --> Completed Trial completion date: May 2018 --> Dec 2018
- || NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: Assessment of Conventional and Patient-specific Instrumentation in Total Knee Arthroplasty (clinicaltrials.gov) - Jun 14, 2018
P=N/A, N=50, Active, not recruiting, Sponsor: Lawson Health Research Institute
Trial completion date: May 2018 --> Dec 2018 Trial completion date: May 2018 --> Aug 2018 | Trial primary completion date: May 2018 --> Aug 2018
- | Enrollment change, Trial completion date, Trial termination, Trial primary completion date, MRI: MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain (clinicaltrials.gov) - Jun 4, 2018
P=N/A, N=87, Terminated, Sponsor: University of Michigan
Trial completion date: May 2018 --> Aug 2018 | Trial primary completion date: May 2018 --> Aug 2018 N=170 --> 87 | Trial completion date: Jul 2018 --> Jun 2017 | Recruiting --> Terminated | Trial primary completion date: Jul 2018 --> Jun 2017; Principal Investigator was unable to fulfill his responsibilities.
- || NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: Facet Wedge Post Market Study (clinicaltrials.gov) - May 3, 2018
P=N/A, N=50, Active, not recruiting, Sponsor: Synthes GmbH
N=170 --> 87 | Trial completion date: Jul 2018 --> Jun 2017 | Recruiting --> Terminated | Trial primary completion date: Jul 2018 --> Jun 2017; Principal Investigator was unable to fulfill his responsibilities. Trial completion date: Feb 2018 --> Aug 2018 | Trial primary completion date: Feb 2018 --> Aug 2018
- | Trial termination: TMC/PyroDisk: PRCT: Ligament Reconstruction & Tendon Interposition With a Joint Spacer for Trapeziometacarpal OA (clinicaltrials.gov) - May 2, 2018
P=N/A, N=82, Terminated, Sponsor: Simon Fraser Orthopaedic Fund
Trial completion date: Feb 2018 --> Aug 2018 | Trial primary completion date: Feb 2018 --> Aug 2018 Active, not recruiting --> Terminated; Study fatigue
- | Prolia (denosumab) / Amgen, Daiichi Sankyo
Trial completion date: ProliaHip: Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women (clinicaltrials.gov) - Apr 30, 2018
P4, N=65, Completed, Sponsor: Turku University Hospital
Active, not recruiting --> Terminated; Study fatigue Trial completion date: Aug 2016 --> Dec 2017
- ||| Trial completion: Study of Subtalar Arthrodesis Using AlloStem (clinicaltrials.gov) - Apr 13, 2018
P=N/A, N=140, Completed, Sponsor: AlloSource
Trial completion date: Aug 2016 --> Dec 2017 Active, not recruiting --> Completed
- | Trial completion, Phase classification, Trial primary completion date: Detecting and Addressing Preclinical Disability (clinicaltrials.gov) - Apr 9, 2018
P, N=148, Completed, Sponsor: McMaster University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: PN/A --> P | Trial primary completion date: Dec 2016 --> Jun 2017
- | Trial completion: Comparing Conservative Therapies for the Alleviation of Knee Pain in Knee Osteoarthritis (clinicaltrials.gov) - Apr 6, 2018
P4, N=50, Completed, Sponsor: Queen's University
Active, not recruiting --> Completed | Phase classification: PN/A --> P | Trial primary completion date: Dec 2016 --> Jun 2017 Recruiting --> Completed
- | Phase classification: The Strong Brain Study (clinicaltrials.gov) - Apr 5, 2018
P, N=18, Completed, Sponsor: University of Florida
Recruiting --> Completed Phase classification: P=N/A --> P
- | Trial completion, Enrollment change, Trial primary completion date: Exercise and Cycle Ergometry Post TKA - A Randomized Controlled Trial (clinicaltrials.gov) - Apr 2, 2018
P=N/A, N=55, Completed, Sponsor: Lakehead University
Phase classification: P=N/A --> P Recruiting --> Completed | N=100 --> 55 | Trial primary completion date: Sep 2017 --> Feb 2018
- Enrollment change: Comparing X-3 To N2vac Polyethylene With the Triathlon Total Knee System (clinicaltrials.gov) - Mar 30, 2018
P4, N=0, Withdrawn, Sponsor: Dalhousie University
Recruiting --> Completed | N=100 --> 55 | Trial primary completion date: Sep 2017 --> Feb 2018 N=384 --> 0
- ||||||| Trial completion, Phase classification, Enrollment change: Epidemiology of Osteoarthritis (OA) Pain (clinicaltrials.gov) - Mar 30, 2018
P, N=86, Completed, Sponsor: Northwestern University
N=384 --> 0 Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=60 --> 86
- Trial primary completion date: Regenexx (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=50, Active, not recruiting, Sponsor: Regenerative Sciences, LLC
Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=60 --> 86 Trial primary completion date: Dec 2017 --> Jun 2018
- | Enrollment change, Trial termination: Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=10, Terminated, Sponsor: Rita Merman
N=50 --> 10 | Recruiting --> Terminated; The computer is crushed and all data is lost (IT was not able to recover it. Last data was collected 6.17.14)
- ||| Trial completion: A Single-Center, Epidemiological Study of the Survivorship of the DePuy Sigma HP Unicompartmental Knee Prosthesis (clinicaltrials.gov) - Mar 22, 2018
P=N/A, N=300, Completed, Sponsor: Mississippi Sports Medicine and Orthopaedic Center
Last data was collected 6.17.14) Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: China Action on Spine and Hip Status (clinicaltrials.gov) - Mar 6, 2018
P=N/A, N=3457, Completed, Sponsor: Beijing Jishuitan Hospital
Active, not recruiting --> Completed Recruiting --> Completed | N=5000 --> 3457 | Trial completion date: Dec 2017 --> Jul 2017 | Trial primary completion date: Jun 2017 --> Jul 2017
- | Trial completion date, Trial primary completion date: Comparison of the Femoral Prothesis-rotation in Conventional X-ray, in Axial CT Slices and 3D-reconstructed CT (clinicaltrials.gov) - Mar 6, 2018
P=N/A, N=50, Recruiting, Sponsor: Michael Tobias Hirschmann
Recruiting --> Completed | N=5000 --> 3457 | Trial completion date: Dec 2017 --> Jul 2017 | Trial primary completion date: Jun 2017 --> Jul 2017 Trial completion date: Jun 2017 --> Mar 2018 | Trial primary completion date: Mar 2017 --> Feb 2018
- | Trial completion date: Study of Subtalar Arthrodesis Using AlloStem (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=140, Active, not recruiting, Sponsor: AlloSource
Trial completion date: Jun 2017 --> Mar 2018 | Trial primary completion date: Mar 2017 --> Feb 2018 Trial completion date: Sep 2017 --> Mar 2018
- | Trial completion, Trial completion date, Trial initiation date, Trial primary completion date: Evaluation of an Educational Program Associated With Exercises (EDEX) Before Total Knee Arthroplasty (clinicaltrials.gov) - Mar 2, 2018
P=N/A, N=262, Completed, Sponsor: Assistance Publique - H
Trial completion date: Sep 2017 --> Mar 2018 Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Dec 2016 | Trial completion date: Oct 2018 --> Nov 2017 | Initiation date: Oct 2012 --> Oct 2012
- | diacerein / Generic mfg.
Trial completion, Trial primary completion date: KAPS: Effect of Interventions on the Progression of Knee Osteoarthritis (clinicaltrials.gov) - Mar 1, 2018
P4, N=322, Completed, Sponsor: Indus Hospital
Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Dec 2016 | Trial completion date: Oct 2018 --> Nov 2017 | Initiation date: Oct 2012 --> Oct 2012 Active, not recruiting --> Completed | Trial primary completion date: Jul 2017 --> Sep 2017
- | Trial completion, Trial completion date, Trial primary completion date: Collaborative-care Intervention to Promote Physical Activity After Total Knee Arthroplasty (clinicaltrials.gov) - Feb 23, 2018
P=N/A, N=45, Completed, Sponsor: University of Colorado, Denver
Active, not recruiting --> Completed | Trial primary completion date: Jul 2017 --> Sep 2017 Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Feb 2018 | Trial completion date: Oct 2017 --> Feb 2018
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Functional Recovery After Total Knee Arthroplasty (clinicaltrials.gov) - Feb 22, 2018
P=N/A, N=80, Completed, Sponsor: Mahidol University
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Feb 2018 | Trial completion date: Oct 2017 --> Feb 2018 Recruiting --> Completed | N=60 --> 80 | Trial primary completion date: May 2017 --> Feb 2018 | Trial completion date: May 2017 --> Feb 2018
- | Trial completion: AViKA: Adding Value in Knee Arthroplasty Post-total Knee Replacement (TKR) Care Navigator Trial (clinicaltrials.gov) - Feb 9, 2018
P=N/A, N=308, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Completed | N=60 --> 80 | Trial primary completion date: May 2017 --> Feb 2018 | Trial completion date: May 2017 --> Feb 2018 Active, not recruiting --> Completed
- piclidenoson (CF101) - Can / Fite, Cipher, China Medical System
Enrollment change, Trial withdrawal: A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee (clinicaltrials.gov) - Feb 1, 2018
P2, N=0, Withdrawn, Sponsor: Can-Fite BioPharma
Active, not recruiting --> Completed N=188 --> 0 | Not yet recruiting --> Withdrawn
- ||||||| Trial completion: Delivra Joint Health Cream In The Treatment Of Pain Caused By Osteoarthritis Of The Knee (clinicaltrials.gov) - Feb 1, 2018
P3, N=160, Completed, Sponsor: Delivra, Inc.
N=188 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- | Trial completion: Management of Hip and Knee Osteoarthritis in Primary Health Care (clinicaltrials.gov) - Feb 1, 2018
P=N/A, N=393, Completed, Sponsor: Diakonhjemmet Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: RSA RCT: ATTUNE (clinicaltrials.gov) - Feb 1, 2018
P=N/A, N=74, Completed, Sponsor: Leiden University Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Phase classification: STAR: Staying Active With Arthritis: RCT of Physical Activity for Older Adults With Osteoarthritis and Hypertension (clinicaltrials.gov) - Jan 31, 2018
P=N/A, N=182, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Phase classification: P3 --> P=N/A
- | Trial primary completion date: A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) With an Interference Screw for Thumb Carpometacarpal Arthritis - Pilot Study (clinicaltrials.gov) - Jan 26, 2018
P=N/A, N=20, Active, not recruiting, Sponsor: Andrew Trenholm
Phase classification: P3 --> P=N/A Trial primary completion date: Nov 2017 --> Feb 2018
- ||| piclidenoson (CF101) - Can / Fite, Cipher, China Medical System
Trial initiation date: A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee (clinicaltrials.gov) - Jan 25, 2018
P2, N=188, Not yet recruiting, Sponsor: Can-Fite BioPharma
Trial primary completion date: Nov 2017 --> Feb 2018 Initiation date: Nov 2016 --> Nov 2018
- Palexia RP (tapentadol extended release) / Assertio, J&J, Grunenthal, Collegium Pharma
Enrollment change, Trial withdrawal, Trial primary completion date: An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR) (clinicaltrials.gov) - Jan 25, 2018
P4, N=0, Withdrawn, Sponsor: Janssen Scientific Affairs, LLC
Initiation date: Nov 2016 --> Nov 2018 N=150 --> 0 | Terminated --> Withdrawn | Trial primary completion date: Apr 2013 --> Aug 2012
- | Trial primary completion date: DePuy Attune Total Knee Arthroplasty RSA Study (clinicaltrials.gov) - Jan 25, 2018
P=N/A, N=30, Active, not recruiting, Sponsor: Michael Dunbar
N=150 --> 0 | Terminated --> Withdrawn | Trial primary completion date: Apr 2013 --> Aug 2012 Trial primary completion date: Dec 2017 --> Dec 2018
- | Trial completion, Phase classification, Trial primary completion date, Surgery: SPARKS: The Study of Physical Activity Rewards After Knee Surgery (clinicaltrials.gov) - Jan 18, 2018
P=N/A, N=202, Completed, Sponsor: Brigham and Women's Hospital
Trial primary completion date: Dec 2017 --> Dec 2018 Recruiting --> Completed | Phase classification: P1/2 --> PN/A | Trial primary completion date: Aug 2016 --> Nov 2016
- | ropivacaine / Generic mfg.
Trial completion, Surgery: Effective Pain Management of Interscalene Blocks During Shoulder Surgery (clinicaltrials.gov) - Dec 20, 2017
P=N/A, N=76, Completed, Sponsor: TriHealth Inc.
Recruiting --> Completed | Phase classification: P1/2 --> PN/A | Trial primary completion date: Aug 2016 --> Nov 2016 Active, not recruiting --> Completed
- ||| New trial: Study of Patient Outcomes 5 Years After Partial Knee Replacement (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=159, Completed, Sponsor: Athens Orthopedic Clinic, P.A.
- | Enrollment closed, Enrollment change, Trial primary completion date: Clinical Outcomes With Omni Apex Ultracongruent Knee System (clinicaltrials.gov) - Dec 13, 2017
P=N/A, N=69, Active, not recruiting, Sponsor: Spokane Joint Replacement Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=56 --> 69 | Trial primary completion date: Nov 2016 --> Nov 2018
- | Enrollment closed, Trial primary completion date: Femoral Remodeling Following Total Hip Arthroplasty With OMNI Apex Modular (clinicaltrials.gov) - Dec 13, 2017
P=N/A, N=73, Active, not recruiting, Sponsor: Spokane Joint Replacement Center
Recruiting --> Active, not recruiting | N=56 --> 69 | Trial primary completion date: Nov 2016 --> Nov 2018 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Nov 2019
- | Enrollment closed, Enrollment change, Trial primary completion date, Surgery: Dual Energy X-ray Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA) (clinicaltrials.gov) - Dec 13, 2017
P=N/A, N=31, Active, not recruiting, Sponsor: Spokane Joint Replacement Center
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Nov 2019 Recruiting --> Active, not recruiting | N=25 --> 31 | Trial primary completion date: Dec 2016 --> Dec 2018
- | Trial completion, Trial primary completion date: Stryker Triathlon (clinicaltrials.gov) - Dec 13, 2017
P=N/A, N=125, Completed, Sponsor: Spokane Joint Replacement Center
Recruiting --> Active, not recruiting | N=25 --> 31 | Trial primary completion date: Dec 2016 --> Dec 2018 Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jul 2016
- | Phase classification, Enrollment change, Trial withdrawal, Trial primary completion date: "Blind" vs. Fluoroscopy-Guided Steroid Injections for Knee Osteoarthritis (clinicaltrials.gov) - Dec 12, 2017
P=N/A, N=0, Withdrawn, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jul 2016 Phase classification: P2 --> P=N/A | N=128 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Apr 2016 --> Jul 2016
- ||| Trial completion: GK10: Cementless Oxford Partial Knee Controlled Observational Study (clinicaltrials.gov) - Dec 8, 2017
P=N/A, N=391, Completed, Sponsor: Zimmer Biomet
Phase classification: P2 --> P=N/A | N=128 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Apr 2016 --> Jul 2016 Active, not recruiting --> Completed
- | Trial primary completion date: KUCE: The Knee Usual Care Evaluation Study (clinicaltrials.gov) - Dec 2, 2017
P=N/A, N=906, Terminated, Sponsor: Hospital for Special Surgery, New York
Active, not recruiting --> Completed Trial primary completion date: Jul 2018 --> Mar 2014